|
|
|
Volumn 272, Issue 1, 1995, Pages 460-468
|
|
The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONCANAVALIN A;
CYTOSTATIC AGENT;
DRUG METABOLITE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
IMMUNOSUPPRESSIVE AGENT;
IONOMYCIN;
LEFLUNOMIDE;
PHORBOL 13 ACETATE 12 MYRISTATE;
PHYTOHEMAGGLUTININ;
RECOMBINANT INTERLEUKIN 2;
RS 61980 000;
TERIFLUNOMIDE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CALCIUM TRANSPORT;
CELL CYCLE PHASE;
CELL GROWTH;
CELL LINE;
CONTROLLED STUDY;
CULTURE MEDIUM;
DOSE RESPONSE;
DRUG MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
LYMPHOCYTE CULTURE;
LYMPHOCYTE PROLIFERATION;
MITOGENESIS;
MONONUCLEAR CELL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
RAT;
SIGNAL TRANSDUCTION;
SPLEEN CELL;
ANIMAL;
ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE;
CALCIUM;
CELL CYCLE;
FEMALE;
IMMUNOSUPPRESSIVE AGENTS;
IN VITRO;
INTERLEUKIN-2;
ISOXAZOLES;
LYMPHOCYTE ACTIVATION;
MICE;
MICE, INBRED BALB C;
PHOSPHOTYROSINE;
PROTEIN-TYROSINE KINASE;
RATS;
RECEPTORS, INTERLEUKIN-2;
TUMOR CELLS, CULTURED;
TYROSINE;
|
|
EID: 0028985102
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (91)
|
|
References (0)
|
